Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients

Pharmacokinetics of Oxaliplatin in Gastrointestinal Cancer Patients with Malignant Ascites

(2014) M. Kochi et al.   JOURNAL OF CHEMOTHERAPY

Cure for peritoneal metastases? An evidence-based review

(2013) Lawson Ung et al.   ANZ JOURNAL OF SURGERY

Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin

(2013) Carlos Pérez-Ruixo et al.   CLINICAL PHARMACOKINETICS

Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)

(2013) Dario Baratti et al.   EUROPEAN JOURNAL OF CANCER

Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery

(2012) Carlos Pérez-Ruixo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

(2012) Stefaan Mulier et al.   CURRENT PHARMACEUTICAL DESIGN

Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

(2012) Terence C. Chua et al.   JOURNAL OF CLINICAL ONCOLOGY

Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model

(2012) Thi Huyen Tram Nguyen et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

(2012) Paul H Sugarbaker et al.   LANCET ONCOLOGY

Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer

(2012) C. William Helm   Surgical Oncology Clinics of North America

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination

(2012) Xiao-Jiang Wu et al.   TUMOR BIOLOGY

Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic Intraperitoneal Oxaliplatin-Induced Neutropenia in Subjects with Peritoneal Carcinomatosis

(2011) Belén Valenzuela et al.   AAPS Journal

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer

(2011) Michael A Ströhlein et al.   Expert Review of Anticancer Therapy

PERMEABILITY OF PERITONEAL AND GLOMERULAR CAPILLARIES: WHAT ARE THE DIFFERENCES ACCORDING TO PORE THEORY?

(2011) B. Rippe et al.   PERITONEAL DIALYSIS INTERNATIONAL

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

(2009) Christopher Cao et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

(2009) Tristan D. Yan et al.   JOURNAL OF CLINICAL ONCOLOGY

A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers

(2008) John H. Stewart et al.   ANNALS OF SURGICAL ONCOLOGY

A Phase I and Pharmacokinetic Study of Weekly Oxaliplatin Followed by Paclitaxel in Patients with Solid Tumors

(2008) T. S. Bekaii-Saab et al.   CLINICAL CANCER RESEARCH

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

(2008) H. Mahteme et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomixoma peritonei

(2008) Tommaso Cioppa et al.   WORLD JOURNAL OF GASTROENTEROLOGY